We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.1B
AUM Growth
+$537M
Cap. Flow
+$109M
Cap. Flow %
1.79%
Top 10 Hldgs %
28.24%
Holding
390
New
23
Increased
194
Reduced
115
Closed
7

Top Buys

Rank Stock Value
1
WEC icon
WEC Energy
WEC
+$48.4M
2
MRK icon
Merck
MRK
+$30.1M
3
GE icon
GE Aerospace
GE
+$27.7M
4
TWX
Time Warner Inc
TWX
+$24.2M
5
SE
Spectra Energy Corp Wi
SE
+$23.5M

Top Sells

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$46M
2
SO icon
Southern Company
SO
+$43.7M
3
IBM icon
IBM
IBM
+$32.6M
4
ADP icon
Automatic Data Processing
ADP
+$21.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$19.8M

Sector Composition

Rank Sector Weight
1 Technology 15.65%
2 Healthcare 15.49%
3 Consumer Staples 15.31%
4 Industrials 11.41%
5 Energy 11.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
126
Sysco
SYY
$39.8B
$3.59M 0.06%
99,355
-2,456
-2% -$83K
KMP
127
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$3.58M 0.06%
44,408
-1,264
-3% -$102K
ORCL icon
128
Oracle
ORCL
$425B
$3.5M 0.06%
91,536
-502
-0.5% -$17.3K
LOW icon
129
Lowe's Companies
LOW
$122B
$3.45M 0.06%
69,692
+2
+0% +$97
PDCO
130
DELISTED
Patterson Companies, Inc.
PDCO
$3.44M 0.06%
83,405
+6,033
+8% +$250K
GWW icon
131
W.W. Grainger
GWW
$61.8B
$3.42M 0.06%
13,385
SO icon
132
Southern Company
SO
$107B
$3.41M 0.06%
83,030
-1,059,224
-93% -$43.7M
BRK.A icon
133
Berkshire Hathaway Class A
BRK.A
$1.11T
$3.38M 0.06%
19
SAP icon
134
SAP
SAP
$225B
$3.31M 0.05%
37,935
-119
-0.3% -$9.46K
ISRG icon
135
Intuitive Surgical
ISRG
$129B
$3.23M 0.05%
75,645
-3,546
-4% -$149K
CLX icon
136
Clorox
CLX
$12.5B
$3.15M 0.05%
33,920
+540
+2% +$48.6K
CL icon
137
Colgate-Palmolive
CL
$73.3B
$3.11M 0.05%
47,624
+7,430
+18% +$476K
EPP icon
138
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$3.1M 0.05%
66,293
-875
-1% -$42.2K
HUB.B
139
DELISTED
HUBBELL INC CL-B
HUB.B
$3.05M 0.05%
28,040
LYB icon
140
LyondellBasell Industries
LYB
$19.7B
$3.01M 0.05%
37,515
+28,965
+339% +$2.22M
XLK icon
141
State Street Technology Select Sector SPDR ETF
XLK
$123B
$3M 0.05%
167,670
+3,610
+2% +$61.2K
STE icon
142
Steris
STE
$22.6B
$2.89M 0.05%
60,149
+4,035
+7% +$184K
LLY icon
143
Eli Lilly
LLY
$998B
$2.83M 0.05%
55,522
-3,762
-6% -$188K
PSMT icon
144
Pricesmart
PSMT
$6.04B
$2.82M 0.05%
24,390
-1,155
-5% -$130K
MON
145
DELISTED
Monsanto Co
MON
$2.75M 0.05%
23,598
+230
+1% +$25.1K
PFE icon
146
Pfizer
PFE
$145B
$2.7M 0.04%
92,930
+62
+0.1% +$1.8K
CTAS icon
147
Cintas
CTAS
$81.4B
$2.63M 0.04%
176,452
WWW icon
148
Wolverine World Wide
WWW
$1.6B
$2.63M 0.04%
77,347
+1,055
+1% +$32.6K
KDP icon
149
Keurig Dr Pepper
KDP
$42.2B
$2.62M 0.04%
53,820
-18,440
-26% -$868K
NSC icon
150
Norfolk Southern
NSC
$76.2B
$2.62M 0.04%
28,214
-100
-0.4% -$8.58K

Similar funds

Bahl & Gaynor's Q4 2013 Portfolio in Review

As of Q4 2013, Bahl & Gaynor held 390 positions worth $6.1B, up 9.7% from $5.56B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor's Q4 2013 filing shows 23 new, 194 increased, 115 reduced and 7 closed positions. Its largest new stake was Time Warner Inc: 373,972 shares worth $25M. The largest sale was Kinder Morgan, an estimated $46M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Bahl & Gaynor's largest Q4 2013 buy was Time Warner Inc: 373,972 shares worth $25M.
  • Bahl & Gaynor added most to WEC Energy in Q4 2013, an estimated $48.4M increase.
  • Bahl & Gaynor's biggest Q4 2013 reduction was Kinder Morgan, cutting an estimated $46M.
  • Bahl & Gaynor fully exited QUESTCOR PHARMA INC in Q4 2013, selling an estimated $499K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $6.1B portfolio in Q4 2013.
  • Bahl & Gaynor opened 23 new positions and closed 7 in Q4 2013.
  • Bahl & Gaynor's portfolio value rose 9.7% quarter-over-quarter to $6.1B.

Based on Bahl & Gaynor's 13F filing for Q4 2013, filed 14 Feb 2014.